Location via proxy:   [ UP ]  
[Report a bug]   [Manage cookies]                

Neurological Emergencies

Download as pdf or txt
Download as pdf or txt
You are on page 1of 47

Neurological Emergencies

ELIAD CULCEA, MD.


ATLAS NEUROLOGY
GREAT FALLS
Alteration in Consciousness
Consciousness

 Arousal
 primitive set of responses

 depends on structures located in the brainstem. ARAS

 Awareness
 high level integration of multiple sensory inputs.

 Resides into the cerebral cortex.


Vegetative state

 Bilateral diffuse cerebral cortex failure.


 Intact arousal mechanism.
 Most commonly results from diffuse anoxic or
ischemic injury.
Brainstem failure

 Impaired arousal mechanisms.


Diagnosis of Consciousness Alterations

 History is important:
 trauma

 illnesses

 medications

 drugs, alcohol.

 Psychiatric disorders.
Physical exam

 General:
 vital signs

 skin (trauma, needle marks, etc)

 head (trauma)

 neck stiffness (attention in trauma)

 chest, abdomen, heart, extremities

 breath (liver dysfunction, alcohol, uremia, ketoacidosis in


diabetes)
Neurological exam

 Observation of patient
 position

 spontaneous motions

 open eyelids and/or hanging jaw =extremely deep coma.


Neurological exam

 Level of consciousness (from mild to severe)


 confusion, delirium

 drowsiness

 stupor

 light coma

 deep coma
Neurological exam

 Position of head and eyes


 deviations of the head and eyes

 spontaneous rowing eye movements

 Funduscopy exam
 Pupils (reactivity to light, asymmetry)
 Doll’s eyes test
 Ice water caloric
Coma etiology

 Non convulsive status epilepticus


 Trauma
 Vascular diseases
 Infectious
 Neoplasms
 Systemic causes
 metabolic
 hypoxic
 toxic
Laboratory Tests

 Routine tests
 Toxins screen
 MRI or CT scan
 Spinal Tap
 EEG
 Angiography
Infections
Infections

 Meningitis
 Viral

 Bacterial

 Fungus

 Encephalitis
 Viral

 Bacterial
 Usually abscess
Clinical Presentation

 Fever
 Headache
 Stiff neck
 Change in the level of consciousness
 Seizures
 History of immunosuppression, head trauma,
sickle cell anemia, local infections.
 Type of bacteria depending on age and immune
status
Diagnosis

 Spinal tap is the most important tool.


 A CT scan of head should be performed.
 PT, PTT and thrombocyte count.
 Informed consent.
CSF Studies

 Tube 1
 glucose (get a fingerstick BS too)

 protein

 Tube 2
 Cultures
 bacterial
 PCR meningitis panel
 AFB,
 fungus cultures
CSF Studies cont.

 Tube 3
 cell count with differential

 Tube 4
 cytology if needed

 Remember to order to hold the remaining CSF


Prognosis

 Depends on the offending agent


 Depends on the age of patient
 Depends on the Immune system status
Treatment

 Initial treatment is empirical based on the age and


other contributory factors.
 When CSF data is available then modify the
treatment accordingly
Status Epilepticus
Status Epilepticus

 Definition
 generalized seizures lasting more than 30 minutes or repeated
seizures without regain of consciousness between the seizures
for 30 minutes.
Status Epilepticus

 Can occur in new onset seizure disorder


 Patient known with seizure disorder who stop
suddenly the medications
 Alcohol withdrawn
 Drug abuse (cocaine, amphetamines)
 CNS infections (especially herpes encephalitis)
Treatment

 Start Lorazepam 1-4 mg iv.


 Prepare and start Fosphenytoin (Cerebrix) 20 mg
PE/Kg IV at a rate of up to 50mg PE/min.
 If seizures not stopped then give IV 10 more
milligrams PE/Kg
 If seizures not stopped then Keppra 1g IV.
 If seizures not stopped then Phenobarbital IV 20
mg/Kg (attention to the BP)
 If seizures not stopped then intubate and start
barbituric coma under EEG monitoring.
Treatment

 After the seizures stopped do further diagnosis tests


to clarify the etiology of the event.
 If possible treat the etiology of the status epilepticus.
Stroke
Stroke

 Ischemic about 90%


 Anterior circulation about 80%

 Posterior circulation about 20%

 Hemorrhagic about 10%


TPA protocol for ischemic stroke

 Inclusion criteria:
 age 18 or older

 time of onset less than 4.5 hours

 clear stroke presentation


 significant weakness
 significant speech difficulty (aphasia)
 substantial visual deficit
 patient awake or drowsy
TPA protocol for ischemic stroke

 Exclusion criteria:
 history of stroke in the previous 3 months

 history of intracranial hemorrhage ever

 serious head trauma in the previous 3 months

 history of GI or urinary bleeding in the previous 21 days

 major surgery in the previous 14 days

 lumbar puncture in the previous 7 days


TPA protocol for ischemic stroke

 Exclusion criteria: (cont.)


 arterial puncture in a non-compressible site

 pregnancy, lactation, or parturition within previous 30 days

 coma

 minor stroke symptoms

 major stroke symptoms improving rapidly

 clinical presentation of arachnoid hemorrhage with normal CT


examination
TPA protocol for ischemic stroke

 Exclusion criteria: (cont.)


 SPB >185 or DBP >110 at the time of treatment
 associated serious medical or terminal illness
 seizure at stroke onset
 acute MI or pericarditis at stroke onset
 platelet count < 100,000
 PT INR >1.7; PTT >37; blood sugar <50 or >400
 hemorrhagic stroke by CT
 in the case of early signs of stroke by CT TPA should
be avoided
TPA protocol for ischemic stroke

 Laboratory orders:
 STAT

CBC, platelet count, PT, PTT, blood sugar, renal


panel
CT of the head
EKG
 review lab results and review inclusion/exclusion
criteria
 treat SPB > 185 or DBP > 110 with Labetalol 1- mg IV
(over 2 min.) can be repeated once after 10 minutes
TPA protocol for ischemic stroke

 Vital signs and neuro checks q 15 min.


 give TPA dose if less than 4.5 hours from stroke
onset
 TPA dose:
 0.9 mg/kg; maximum dose 90 mg regardless of the patient weight.
 10% is given in bolus over 1 minute and the remaining 90%
infused over 60 minutes)
Mechanical Thrombectomy

 Major advancement in stroke care


 We have robust data and indications for the anterior
circulation large vessels occlusion
 Obtain CTA after TPA is administrated
 Obtain CTA if there are contraindications to the TPA
and the time of onset is less than 24 hours
 Perfusion/diffusion mismatch
Myasthenia Gravis
Myasthenia Gravis

 Autoimmune disorder were antibodies are directed


toward neuromuscular junction acetylcholine
receptors.
 Basic treatment consists in:
 Anticholinesterase drugs
 drugs that induce immunosuppression
Myasthenic crisis

 Changes in the absorption of medication or the


natural worsening of the disease may cause
increased weakness
 Anticholinesterase medication have a bell-shaped
dose-response curve and too much medication can
induce weakness
Myasthenic crisis

Medications that can worsen the


neuromuscular junction transmission
 Quinine  Polymixin
 Quinidine  Viomycin
 Procainamide  Colistin
 Propranolol  Morphine
 Lidocaine  Barbiturates
 Aminoglycoside  Sedatives
 Quinolones  Magnesium
supplements
Myasthenic crisis

 Treatment
 admit into intensive care unit for monitoring

 monitor respiratory function and not the pulse oximetry

 intubate electively if decrease in respiratory function or in


difficulties in protecting the airways
 plasmapheresis or IVIG can be used for the treatment
Myasthenic crisis

 If patient is intubated you can decrease the


anticholinesterase drugs to see if the weakness is due
to overdose
 If patient is on oral pyridostigmine (Mestinon) and
you want to give it IV the ratio oral/IV is 30/1 mg
Guillain Barré
Syndrome
Guillain Bare Syndrome

 Autoimmune disorder
 Antibodies directed toward peripheral nerves myelin
sheets
 Usually occurs a couple of weeks after a viral illness
 Patient has progressive weakness that starts distally
 It may involve respiratory muscles
Guillain Bare Syndrome

 Patient needs monitoring of respiratory function and


not pulse oximetry
 Intubate electively if decreased in respiratory
function or difficulty protecting the airways
 Treatment is either plasmapheresis or IVIG, the
steroids are not useful.
Spinal cord
compression
Spinal cord compression/myelopahy

 Trauma
 Disc herniation
 Synovial cysts
 Medical conditions
 metastasis
 multiple myeloma
 lymphomas
 lung cancer
 breast cancer
 prostate cancer
 kidney cancer
 sarcomas
Spinal cord compression/myelopathy

 Clinical features
 Examination shows upper motor neuron signs
 Babinsky present
 Brisk DTR
 prodrome (can precede the event weeks to months)
 unremitting severe back pain
 unremitting severe radicular pain
 or both
 stage of spinal compression
 subtle weakness and/or numbness in the legs
 urinary hesitancy, urgency and retention
 in a few day patient becomes paraplegic
Spinal cord compression/myelopathy

 MRI with contrast or CT myelogram are the exams of


choice
 Spinal cord ends at L1, obtain the imaging of the proper CNS
section/s
 Plain CT of spine is not enough
 Treatment
 Directed by the nature of the spinal cord lesion

 IV steroids

 radiation therapy

 surgery

You might also like